Flowflex SARS-CoV-2 Antigen Rapid Tests have gained Health Canada sales & import authorisation for lab-based and point of care testing.
The Health Canada has assessed the relative sensitivity & specicificity, and accurancy of each approved test, with Flowflew performing as follows:
- Relative Sensitivity: 97.1%
- Relative Specificity: 99.5%
- Accuracy: 98.8%
The tests are authorised for the following applications & settings:
- Lab-based tests, which are conducted in a lab environment by a trained laboratory technician.
- Point-of-care testing when used by an approved operator (often a health care professional) in a near-patient environment, such as a medical office or at the bedside. The patient waits for the results.
The list authorised tests in Canada can be found HERE.
To find out more visit the product page HERE, or for enquiries and orders please submit the contact form below, or call the team on +44 (0) 114 2213344.
